|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:awards
|
gptkb:Forbes_Asia's_Fab_50_Companies
|
|
gptkbp:CEO
|
gptkb:Vinita_Gupta
|
|
gptkbp:country
|
gptkb:India
|
|
gptkbp:focusArea
|
pediatrics
anti-infectives
cardiovascular drugs
respiratory drugs
CNS (central nervous system)
diabetes drugs
gastrointestinal drugs
|
|
gptkbp:foundedBy
|
gptkb:Desh_Bandhu_Gupta
|
|
gptkbp:foundedYear
|
1968
|
|
gptkbp:hasResearchCenter
|
gptkb:India
gptkb:United_States
|
|
gptkbp:headquartersLocation
|
gptkb:Mumbai
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Lupin Limited
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:ISIN
|
INE326A01037
|
|
gptkbp:listedOn
|
gptkb:Bombay_Stock_Exchange
gptkb:National_Stock_Exchange_of_India
|
|
gptkbp:manufacturingFacilities
|
gptkb:Australia
gptkb:Brazil
gptkb:Europe
gptkb:India
gptkb:Indonesia
gptkb:Japan
gptkb:Mexico
gptkb:Philippines
gptkb:South_Africa
gptkb:United_States
|
|
gptkbp:market
|
global
|
|
gptkbp:notableAcquisition
|
gptkb:Anglo-French_Drugs_&_Industries
gptkb:Gavis_Pharmaceuticals
gptkb:Hormosan_Pharma
gptkb:Kyowa_Pharmaceutical_Industry_Co.
gptkb:Medquímica_Indústria_Farmacêutica
gptkb:Nanomi_B.V.
gptkb:Pharma_Dynamics
gptkb:Southern_Cross_Pharma
gptkb:Temmler_Pharma
|
|
gptkbp:numberOfEmployees
|
over 20,000
|
|
gptkbp:parentCompany
|
gptkb:Lupin_Group
|
|
gptkbp:products
|
generic drugs
active pharmaceutical ingredients
branded formulations
|
|
gptkbp:publiclyTraded
|
yes
|
|
gptkbp:revenue
|
over $2 billion (2023)
|
|
gptkbp:stockExchange
|
gptkb:NSE
BSE
|
|
gptkbp:stockSymbol
|
gptkb:LUPIN
|
|
gptkbp:subsidiary
|
gptkb:Lupin_Pharmaceuticals,_Inc.
|
|
gptkbp:website
|
https://www.lupin.com/
|
|
gptkbp:bfsParent
|
gptkb:Pune,_Maharashtra,_India
|
|
gptkbp:bfsLayer
|
6
|